Methyl iodide → HCID 56665092, compound

HRID 2098026Notes

Reaction equation

HRID 2098026 reaction equation
[H-].[Na+].[Br:3][C:4]1[C:5]([C:24]2[N:28]=[CH:27][NH:26][N:25]=2)=[C:6]([NH:9][C:10](=[O:23])[CH2:11][N:12]2[C:21]3[C:16](=[N:17][CH:18]=[CH:19][CH:20]=3)[CH2:15][CH2:14][C:13]2=[O:22])[S:7][CH:8]=1.I[CH3:30]>CN(C=O)C.O>[Br:3][C:4]1[C:5]([C:24]2[N:28]=[CH:27][N:26]([CH3:30])[N:25]=2)=[C:6]([NH:9][C:10](=[O:23])[CH2:11][N:12]2[C:21]3[C:16](=[N:17][CH:18]=[CH:19][CH:20]=3)[CH2:15][CH2:14][C:13]2=[O:22])[S:7][CH:8]=1

Participants

6

Procedure

Sodium hydride (4.2 mg of a 60% dispersion in mineral oil, 0.107 mmol) was added to a solution of N-(4-bromo-3-(1H-1,2,4-triazol-3-yl)thiophen-2-yl)-2-(2-oxo-3,4-dihydro-1,5-naphthyridin-1(2H)-yl)acetamide (31 mg, 0.0715 mmol) in DMF (0.1 mL) at 0° C. The suspension was stirred for 5 minutes after which iodomethane (12 mg, 0.058 mmol) was added. The reaction mixture was stirred at room temperature for 20 minutes then diluted with water, extracted with ethyl acetate, dried (Na2SO4), filtered, concentrated under vacuum and purified by preparative HPLC to give N-(4-bromo-3-(1-methyl-1H-1,2,4-triazol-3-yl)thiophen-2-yl)-2-(2-oxo-3,4-dihydro-1,5-naphthyridin-1(2H)-yl)acetamide. Retention time (min)=1.740, method [7], MS (ESI) 447.0 (M+H); 1H NMR (300 MHz, CD3OD) δ 8.47 (s, 1H), 8.33 (d, J=5.2 Hz, 1H), 7.85 (bs, 1H), 7.61 (bs, 1H), 7.11 (s, 1H), 4.94 (s, 2H), 4.02 (s, 3H), 3.41-3.36 (m, 2H), 3.01-2.97 (m, 2H).

Workup

  1. additionwas added
  2. extractionextracted with ethyl acetate
  3. dry with materialdried (Na2SO4)
  4. filtrationfiltered
  5. concentrationconcentrated under vacuum
  6. custompurified by preparative HPLC

Sources & evidence

ORD record
ord-de1a00a7c35440229846294fd21ca5e3
Source dataset
uspto-grants-2013_05
Patent number
US08450363B2

Reaction notes

Loading…